my and Cell Biology aims to provide our students with the best possible education and to ensure patient-oriented research by combining research and teaching. Please do not hesitate to contact us. With
these antibody-producing B cells before they can cause any damage, we use other immune cells of the patient – the so-called T cells – which we convert into killer cells through genetic modification so that [...] soon build up a CORA T-cell bank with the most common HLA variants and then make these available to patients for customised transplants. "This approach would also help to improve the existing problem of living
They care for patients, take on administrative and documentation tasks and organise workflows. They work in outpatient clinics, practices, clinics and health centres. “In the future, patient care and prevention
system, hormones, nervous system) will guide the development of targeted, personalized therapies for patients. Our research is supported by the DFG, DZIF, BMBF, KWS Lochow GmbH, Hetzler Foundation and intramural [...] Solbach P, Lenzen H, Potthoff A, Manns MP, Wedemeyer H, Pieper DH (2018). Intestinal microbiota in patients with chronic hepatitis C with and without cirrhosis compared with healthy controls. Liver Int 3
treatment with mistletoe extracts for patients with breast cancer compared to conventional cancer therapy alone–efficacy and safety, costs and cost-effectiveness, patients and social aspects, and ethical assessment
in cardiovascular diseases, and in clinical studies, new diagnostic and management concepts for patients with art. Hypertension (high blood pressure). Organ or tissue damage causes an inflammatory response [...] In a clinical registry study, we are testing novel and simplified algorithms for the work-up of patients with refractory hypertension. Selected publications Richter B*, Kapanadze T*, Weingärtner N, Walter [...] Unger T, Haller H, Limbourg FP. Antihypertensive prescription patterns and cardiovascular risk in patients with newly diagnosed hypertension- an analysis of statutory health insurance data in Germany. Blood
pursuing the goal that their approach should offer in future an alternative, personalized therapy for patients who are currently dependent on a left ventricular assist system (LVAD) as a “bridge to-repair” strategy
experiments don't lead to anything even after two years - that's normal in science. But if you stay patient and persevere and keep digging deeper, you will get results!" Novel viral diseases (emerging infections)
each visit to the outpatient clinic) We kindly ask the parents, also in the interest of the other patients, to arrive punctually at the agreed time. If you are unable to attend, please call the outpatient
talked to Prof. Dr. Thomas Illig. The HUB is currently establishing a COVID-19 cohort with 1000 patients and control groups. Additionally, Prof. Dr. Thomas Illig and Prof. Dr. Jörg Vehreschild from Cologne